Sunday, November 19, 2023 4:10:33 PM
The reason? When testing becomes a commodity, it means it’s widely used. Myriad was the original owner of the patent and therefore developed the expertise to employ this testing.
I’m thinking, and this would be ambitious, HDC could do the same with their expired patents. Although they’re no longer “exclusive” with the technology, they can market it as a “me too” product with the advantage of being the experts (as was Myriad to the BRCA genes).
You are looking at this through the 2.2 mil lens but this re-launching of HDC is viewed from the "more to come" lens. But again, I'm not arguing for this outcome, only that there is more to come than the 2.2 mil.
Even the mere mention that this is a scam shows a profound lack of DD, critical thinking skills or honesty.
Recent HDVY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 07:10:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 09:13:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 07:53:39 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM